This policy is geared towards reducing the incidence, prevalence, and impact of ear diseases and hearing disorders by ensuring quality, accessible, equitable and affordable hearing care to prevent hearing loss to Nigerians.

The goal of this policy is to have a malaria-free Nigeria. The strategy adopted by this policy includes increased private sector participation, promoting innovative malaria intervention, increased government budgeting for malaria intervention, and behavioural change to prevent and treat malaria.

This guideline was developed to track maternal and perinatal deaths in Nigeria in a bid to improve the knowledge and skills of health care providers in maternal and new-born care.

This document provides a framework to develop and implement the National Family Planning Communication Campaigns with the overall goal of decreasing maternal and infant morbidity and mortality rates in Nigeria. It focuses on increasing the knowledge of women of reproductive age on modern family planning methods.

This policy aims to ensure the adequate supply of drugs at an affordable, safe and of the required standard, to ensure rational and proper use of drugs and to promote the domestic production of essential drugs.

The goal of this policy is to institutionalize, coordinate and regulate the use of ambulance services for emergency medical services in Nigeria.

This document aims at the provision of a framework for the integration of Adolescents and Youth Friendly Services(AYFHS) into the existing Primary Health Care facilities in Nigeria. This document builds on the National Policy on the Health & Development of Adolescents and Young People in Nigeria.

This policy document provides the direction for improving the performance of the Nigerian health system. The policy emphasizes strengthening primary health and collaboration of stakeholders including the private sector in the implementation of the policy.

The guidelines are a reference to drug distribution in Nigeria. The document stipulates how states are to establish State Drug Distribution Centers (SDDCs) and how the private sector is to establish Mega Drug Distribution Centers (MDDCs). These guidelines are based on the provisions of the National Drug Policy (NDP).

This document is designed to guide provision of home care for persons with confirmed COVID-19 infection who are asymptomatic or who have mild symptoms. It emphasizes that home care should also be considered when in-patient care is unavailable or unsafe (e.g. limited capacity, resources).

This document details on guidelines to reduce physical contact between people to slow down and reduce the spread of COVID-19 in Nigeria.

The purpose of this document is to provide key public health guidance to be considered while conducting elections during the COVID-19 pandemic. It provides recommendations and actions that should be taken to reduce the risk of exposure to COVID-19 for all voters, electoral officers, candidates and other participants.

This document guides how dead bodies/remains of patients suspected or confirmed to have died of COVID-19 can be safely transported between states or across international boundaries.

This document was developed to guide engagement with the private sector medical laboratories to help accelerate the availability of COVID-19 diagnostic testing for the duration of the public health emergency.

The objective of the manual is to provide Community Health Extension Workers (CHEWs) with the management skills necessary to provide quality Long-Acting Reversible Contraceptive (LARC) methods in Nigeria.

This document provides guidelines for the management of pregnant women and nursing mothers during the COVID-19 pandemic. It makes provisions for care for both expectant mothers and expectant mothers with suspected or confirmed COVID-19.

This document provides strategies to improve surveillance for COVID-19 in the thirty-six states of Nigeria. It provides categories for testing; strategies to scale up case identification and sample collection; methods for case identification; and strategies for demand creation for sample collection.

This regulatory document provides guidelines to curb the spread of COVID-19 in Nigeria.

This strategic framework outlines the primary, secondary and tertiary prevention interventions and rehabilitation and reintegration strategies that will ensure that the incidence of Obstetric Fistula is reduced by 50% in Nigeria.

This Act establishes the National Institute for Cancer Research and Treatment of Cancer patients in Nigeria. Among other things, the institute shall provide national leadership in cancer research, control and treatment, guide scientific improvements to cancer prevention, treatment and care, coordinate and liaise between the wide range of groups and health care providers with an interest in cancer.